New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Point-of-care therapeutics sensor could make automated dosing systems universal

Point-of-care therapeutics sensor could make automated dosing systems universal

by Jade Boyd,Rice UniversityA prototype electronic sensor that emits current when it detects the anticancer drug afimoxifene. Rice University synthetic biologists created the device to demonstra
Technology & AI March 20,2024
Point-of-care therapeutics sensor could make automated dosing systems universal

Point-of-care therapeutics sensor could make automated dosing systems universal

by Jade Boyd,Rice UniversityA prototype electronic sensor that emits current when it detects the anticancer drug afimoxifene. Rice University synthetic biologists created the device to demonstra
Technology & AI March 20,2024
Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic

Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for t
Breakthroughs March 20,2024
Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic

Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for t
Breakthroughs March 20,2024
An aspirin a day? Poll of older adults suggests some who take it may be following outdated advice

An aspirin a day? Poll of older adults suggests some who take it may be following outdated advice

by University of MichiganCredit: Pixabay/CC0 Public DomainOne in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll sh
Breakthroughs March 20,2024
An aspirin a day? Poll of older adults suggests some who take it may be following outdated advice

An aspirin a day? Poll of older adults suggests some who take it may be following outdated advice

by University of MichiganCredit: Pixabay/CC0 Public DomainOne in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll sh
Breakthroughs March 20,2024
Long-acting injectable ART superior to standard care for poorly adherent people with HIV

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral
Public Health & Prevention March 20,2024
Long-acting injectable ART superior to standard care for poorly adherent people with HIV

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral
Public Health & Prevention March 20,2024
Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainThrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonst
Neurology March 20,2024
Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainThrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonst
Neurology March 20,2024
'Study drugs' shown to set the stage for other drug use and mental health decline

'Study drugs' shown to set the stage for other drug use and mental health decline

by Binghamton UniversityCredit: Pixabay/CC0 Public DomainTaking "study drugs" like Adderall without a diagnosis is not only dangerous in itself but can lead to other drug use and a decl
Breakthroughs March 20,2024
'Study drugs' shown to set the stage for other drug use and mental health decline

'Study drugs' shown to set the stage for other drug use and mental health decline

by Binghamton UniversityCredit: Pixabay/CC0 Public DomainTaking "study drugs" like Adderall without a diagnosis is not only dangerous in itself but can lead to other drug use and a decl
Breakthroughs March 20,2024
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle
Diabetes & Endocrinology March 20,2024
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle
Diabetes & Endocrinology March 20,2024
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

by Hassan Vally,The ConversationCredit: Pixabay/CC0 Public DomainAttention-deficit hyperactivity disorder (ADHD) can have a considerable impact on the day-to-day functioning and overall well-bei
Breakthroughs March 20,2024
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

by Hassan Vally,The ConversationCredit: Pixabay/CC0 Public DomainAttention-deficit hyperactivity disorder (ADHD) can have a considerable impact on the day-to-day functioning and overall well-bei
Breakthroughs March 20,2024
Poor trial results may prompt maker to pull ALS drug from market

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Breakthroughs March 20,2024
Poor trial results may prompt maker to pull ALS drug from market

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Breakthroughs March 20,2024
Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

by Ian Hamilton and Harry Sumnall,The ConversationCredit: Pixabay/CC0 Public DomainThere has been a significant rise in deaths linked to the commonly prescribed anxiety drug, pregabalin. While i
Breakthroughs March 20,2024
Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

by Ian Hamilton and Harry Sumnall,The ConversationCredit: Pixabay/CC0 Public DomainThere has been a significant rise in deaths linked to the commonly prescribed anxiety drug, pregabalin. While i
Breakthroughs March 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com